Blood Research 2017;52(1):3-6
doi:10.5045/br.2017.52.1.3
The Consortium for Improving Survival of Lymphoma (CISL): recent achievements and future perspective.
Cheolwon SUH 1 ; Byeong Bae PARK ; Won Seog KIM
Affiliations
Country
Republic of Korea
Language
English
MeSH
ACTIONS
Abstract
No abstract available.
备案号: 11010502037788, 京ICP备10218182号-8)